Response to treatment in man of multi-drug resistant Plasmodium falciparum from Panama.
D000328:Adult; D000655:Amodiaquine / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000852:Anopheles; D000962:Antimalarials / Q000494:pharmacology / Q000627:therapeutic use*; D002738:Chloroquine / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D000882:Haplorhini; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D010176:Panama; D010963:Plasmodium falciparum / Q000187:drug effects; D002727:Proguanil / Q000494:pharmacology / Q000627:therapeutic use; D011739:Pyrimethamine / Q000494:pharmacology / Q000627:therapeutic use; D011803:Quinine / Q000494:pharmacology / Q000627:therapeutic use; D012008:Recurrence; D013411:Sulfadiazine / Q000494:pharmacology / Q000627:therapeutic use
D000962:Antimalarials; D013411:Sulfadiazine; D000655:Amodiaquine; D002738:Chloroquine; D011803:Quinine; D002727:Proguanil; D011739:Pyrimethamine